Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

(2018) D Westover et al.   ANNALS OF ONCOLOGY

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

(2018) Shang-Gin Wu et al.   Molecular Cancer

Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells

(2017) Lian-Xiang Luo et al.   Frontiers in Pharmacology

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors

(2016) Jung Min Song et al.   Oncotarget

Traditional Chinese medicine and cancer: History, present situation, and development

(2015) Jie Liu et al.   Thoracic Cancer

Assessment of Erlotinib as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Patients

(2014) Eben L. Rosenthal et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epidermal Growth Factor Receptor Potentiates MCM7-Mediated DNA Replication through Tyrosine Phosphorylation of Lyn Kinase in Human Cancers

(2013) Tzu-Hsuan Huang et al.   CANCER CELL

Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities

(2013) Ankit Kumar et al.   Future Medicinal Chemistry

Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells

(2013) Parnetta Sutton et al.   Molecular Cancer

Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor

(2012) M Iida et al.   ONCOGENE

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

(2010) R. J. Leeman-Neill et al.   CLINICAL CANCER RESEARCH

Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent

(2009) Levi E. Fried et al.   ANTIOXIDANTS & REDOX SIGNALING

Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells

(2009) Eun-Jung Park et al.   CANCER LETTERS

Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells

(2009) Dae-Hee Lee et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model

(2008) Qi-qi Jiang et al.   BMC CANCER